Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H38N2O4.2ClH |
Molecular Weight | 551.545 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.[H][C@@]12CC(C[C@H]3NCCC4=CC(OC)=C(OC)C=C34)=C(CC)CN1CCC5=CC(OC)=C(OC)C=C25
InChI
InChIKey=WNJZDNXVVDNPSI-FJEGXLQFSA-N
InChI=1S/C29H38N2O4.2ClH/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24;;/h13-16,24-25,30H,6-12,17H2,1-5H3;2*1H/t24-,25+;;/m1../s1
Oral dehydroemetine dihydrochloride (+/-) (Mebadin) was found useful both as a tissue and contact amoebicide. It is much less toxic and more active than emetine and can be given in larger doses and for longer periods with safety. Owing to the quick excretion, repeat courses can be given at short intervals, as necessary, without danger. No serious side effects were noted particularly with the oral form and it was far better tolerated by children, who received relatively higher dosage than most adults. The only contra-indication is for patients with manifest decompensation of vital organs, or fevers. Mebadin injection and Mebadin tablets are discontinued products.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Ventricular tachycardia in a patient on dehydroemetine and chloroquine for amoebic liver abscess. | 1979 May 5 |
|
HIV-1 and HIV-2 reverse transcriptases: a comparative study of sensitivity to inhibition by selected natural products. | 1992 May 29 |
|
Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs. | 1992 Sep |
|
[Fasciola hepatica. study of a series of 37 patients]. | 2001 Oct |
|
Sonographic findings of hepatic lesions in human fascioliasis. | 2003 Sep |
|
Histopathology of cutaneous amebiasis. | 2004 Aug |
|
Development of a pharmacodynamic screening model with Entamoeba histolytica. | 2007 |
|
Targeting HSP90 for cancer therapy. | 2009 May 19 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DEHYDROEMETINE DIHYDROCHLORIDE
Created by
admin on Sat Dec 16 06:23:14 UTC 2023 , Edited by admin on Sat Dec 16 06:23:14 UTC 2023
|
PRIMARY | Description: A white to yellowish, crystalline powder; odourless.Solubility: Sparingly soluble in water; soluble in methanol R.Category: Antiamoebic drug.Storage: Dehydroemetine dihydrochloride should be kept in a tightly closed container. | ||
|
218-766-1
Created by
admin on Sat Dec 16 06:23:14 UTC 2023 , Edited by admin on Sat Dec 16 06:23:14 UTC 2023
|
PRIMARY | |||
|
2228-39-9
Created by
admin on Sat Dec 16 06:23:14 UTC 2023 , Edited by admin on Sat Dec 16 06:23:14 UTC 2023
|
PRIMARY | |||
|
6Y45FL9GWY
Created by
admin on Sat Dec 16 06:23:14 UTC 2023 , Edited by admin on Sat Dec 16 06:23:14 UTC 2023
|
PRIMARY | |||
|
236465
Created by
admin on Sat Dec 16 06:23:14 UTC 2023 , Edited by admin on Sat Dec 16 06:23:14 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID50944940
Created by
admin on Sat Dec 16 06:23:14 UTC 2023 , Edited by admin on Sat Dec 16 06:23:14 UTC 2023
|
PRIMARY | |||
|
21124735
Created by
admin on Sat Dec 16 06:23:14 UTC 2023 , Edited by admin on Sat Dec 16 06:23:14 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD